Olema Pharmaceuticals (OLMA)
(Delayed Data from NSDQ)
$4.64 USD
-0.08 (-1.69%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $4.63 -0.01 (-0.22%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Olema Pharmaceuticals, Inc. has a market cap of $322.95M, which represents its share price of $4.72 multiplied by its outstanding shares number of 68.42M. As a small-cap company, OLMA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
OLMA 4.64 -0.08(-1.69%)
Will OLMA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for OLMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OLMA
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High?
Wall Street Analysts Think Olema Pharmaceuticals (OLMA) Could Surge 433.13%: Read This Before Placing a Bet
OLMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -30.16% in 4 Weeks, Here's Why the Trend Might Reverse for Olema Pharmaceuticals (OLMA)
Novartis' Gene Therapy Meets Primary Endpoint in SMA Study
Novartis Announces Positive Results From Late-Stage Study on Fabhalta
Other News for OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OLMA Stock News
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OLMA Stock News
Olema Pharmaceuticals Holds Annual Stockholders Meeting
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | OLMA Stock News
12 Health Care Stocks Moving In Monday's Intraday Session